| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Iris Plans provides telehealth Advance Care Planning (ACP) services to health insurers and health care providers, reducing unnecessary care for people with serious medical conditions. ACP lowers the cost of care while improving quality and experience.
M and S Technologies, Inc. is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Trailblazer Health Enterprises, LLC is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mobile Medical Intl is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.